Lee Anna Jones
- Molecular Biology
- Genetics top 10%
- Epidemiology
- Oncology
- Nephrology top 10%
- Co-authors
- Alan S. CohenRobert W. SimmsCaryn LibbeyRodney H. FalkJennifer J. AndersonJames SkareMartha SkinnerAubrey Milunsky
- Topics
- Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers)Protein Kinase Regulation and GTPase Signaling (2 papers)Hematological disorders and diagnostics (2 papers)
- Cited by
- NephrologyGeneticsMolecular Biology
- Journals
- The American Journal of MedicineOphthalmologyBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Lee Anna Jones
11 papers receiving 457 citations
Peers
Comparison fields: 5 of 53
- Molecular Biology 409
- Genetics 96
- Epidemiology 87
- Oncology 71
- Nephrology 70
Countries citing papers authored by Lee Anna Jones
This map shows the geographic impact of Lee Anna Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Anna Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Anna Jones more than expected).
Fields of papers citing papers by Lee Anna Jones
This network shows the impact of papers produced by Lee Anna Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Anna Jones. The network helps show where Lee Anna Jones may publish in the future.
Co-authorship network of co-authors of Lee Anna Jones
This figure shows the co-authorship network connecting the top 25 collaborators of Lee Anna Jones. A scholar is included among the top collaborators of Lee Anna Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee Anna Jones. Lee Anna Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 9 | |
| 3 | 24 | |
| 4 | 38 | |
| 5 | 266 | |
| 6 | 34 | |
| 7 | 19 | |
| 8 | 20 | |
| 9 | 21 | |
| 10 | Proline at position 36: a new transthyretin mutation associated with familial amyloidotic polyneuropathy. | 37 |
| 11 | Subacute thyroiditis after bone marrow transplant for chronic granulocytic leukaemia. | 3 |
About Lee Anna Jones
Lee Anna Jones is a scholar working on Emergency Medicine, Nephrology and Rheumatology, having authored 11 papers that have together received 472 indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and Hematological disorders and diagnostics (2 papers). The work is most often cited by research in Nephrology (70 citations), Genetics (96 citations) and Molecular Biology (409 citations). Lee Anna Jones has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Alan S. Cohen, Robert W. Simms, Caryn Libbey, Rodney H. Falk, Jennifer J. Anderson, James Skare, Martha Skinner, Aubrey Milunsky, Jennifer Harding and W. David Lewis. Their work appears in journals such as The American Journal of Medicine, Ophthalmology and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.